Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β

NCT05854251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hyperinsulinemia
PreDiabetes

Interventions

DRUG: Anakinra
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland